SynthesisVirology journal2025

Efficacy and safety of 3CL protease inhibitors in patients with mild or moderate COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Nicole Jean Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.